Medical News

Epstein-Barr Virus –⁠ Is the Culprit of MS Revealed?

23. 5. 2022 Source: Multiple Sclerosis

Could the Epstein-Barr virus hold the answer to the etiology of multiple sclerosis? A dataset of over 10 million American recruits offered intriguing insights. You may have encountered the conclusions of one of the most extensive studies in modern history in the media. Let's take a closer look at the work of Kjetil Bjornevik and his colleagues.

From Biomarker Testing to NSCLC Treatment Selection

During a satellite symposium at this year's European Lung Cancer Congress (ELCC 2022), Prof. Martin Reck from the Department of Thoracic Oncology at the hospital in Grosshansdorf, Germany, discussed…

23. 5. 2022 Source: Non-Small Cell Lung Cancer

Is Adding Fibrinogen Concentrate to Transfusion Therapy for Postpartum Hemorrhage an Effective Approach?

Significant postpartum hemorrhage can be managed with fresh frozen plasma transfusion. However, administering larger volumes is associated with several risks. The authors of the Japanese study below…

20. 5. 2022 Source: Life-threatening Bleeding

Administration of Fibrinogen Concentrate in Patients with Persistent Bleeding After Cardiac Surgery

Is the administration of fibrinogen concentrate in patients with persistent bleeding after initial cardiac surgery associated with an increased risk of thromboembolic events or death? Authors of a…

20. 5. 2022 Source: Life-threatening Bleeding

Prediction of DM2 and CVD Development Risk Based on Lipidomic Risk Determination

The incidence of type 2 diabetes mellitus (DM2) and cardiovascular diseases (CVD) is strongly influenced by lifestyle and diet. Hypertension, hypercholesterolemia, and elevated blood glucose are…

20. 5. 2022 Source: Modern Treatment of Diabetes

Psychiatry of Transitional Age −⁠ An Important Area That Has Not Yet Received Much Attention

Three-quarters of psychiatric disorders develop before the age of 25, with up to half of these disorders appearing before the age of 16. The period of so-called emerging adulthood thus represents a…

19. 5. 2022 Source: Modern Treatment of Schizophrenia

Erlotinib in Conditions of Routine Clinical Practice

The patient population in clinical trials is always somewhat selected. Only a well-conducted analysis of real-world clinical practice data can provide a clearer picture of the efficacy and safety of…

18. 5. 2022 Source: Oncological Treatment

What can we base the decision on for the choice of initial treatment modality for CLL?

We now have a range of highly effective treatment options for patients with chronic lymphocytic leukemia (CLL). New drugs have significantly contributed to improved overall survival (OS). However,…

18. 5. 2022 Source: Chronic Lymphocytic Leukemia

Update of International Recommendations for the Diagnosis and Treatment of Hereditary Angioedema from 2021

The aim of the 2021 update of the recommendations for the diagnosis and treatment of hereditary angioedema (HAE) is to help doctors answer important clinical questions: How to diagnose HAE? When and…

18. 5. 2022 Source: Hereditary Angioedema

Management of Musculoskeletal Issues in Hemophiliacs at a Glance

Musculoskeletal issues are among the most common complications of hemophilia. Prevention and early treatment are crucial, and this message is also addressed to specialists by the World Federation of…

17. 5. 2022 Source: Hemophilia with Movement

Progress on Lorlatinib –⁠ What's Next?

Lorlatinib is currently mainly used in the 2nd and later lines of treatment for non-small cell lung cancer (NSCLC) with ALK gene rearrangement. Clinical research is now focusing on the question of…

17. 5. 2022 Source: Genetic Profile and Treatment of NSCLC

Debate on Sepsis Biomarkers 'on Blood'

Sepsis represents a major cause of death from infectious diseases. Early identification of patients with a prognosis of sepsis is therefore crucial for their survival and prognosis. In addition to…

16. 5. 2022 Source: Because

Current and Future Possibilities for Influencing Immune Thrombocytopenia

The possibilities for treating immune thrombocytopenia (ITP) are quite broad today, with a major advancement for many patients being the advent of thrombopoietin receptor agonists. However, for some…

16. 5. 2022 Source: Immune Thrombocytopenia

ID 360 –⁠ Immunodeficiency in Interdisciplinary Collaboration 2022

For the second time, a two-day meeting titled "ID 360 –⁠ Immunodeficiency in Interdisciplinary Collaboration" took place, this time on March 25–26, 2022, in Prague. Several current topics were…

13. 5. 2022 Source: Primary and Secondary Immunodeficiencies

According to which parameters can we best assess the quality of incontinence aids?

Properly chosen incontinence aid significantly influences the user's quality of life. When selecting incontinence aids, it is very important to consider their individual properties and parameters.…

12. 5. 2022 Source: Incontinence

1 … 50 51 52 53 54 … 111

Back Filter by speciality

Remove filters

Popular this week